Log In
Print
BCIQ
Print
Print this Print this
 

CPI-0610

  Manage Alerts
Collapse Summary General Information
Company Constellation Pharmaceuticals Inc.
DescriptionBET bromodomain inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLymphoma
Indication DetailsTreat lymphoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today